Skip to main content
Advertisement

Main menu

  • Home
  • Content
    • Current Issue
    • Accepted Manuscripts
    • Article Preview
    • Past Issue Archive
    • Video Articles
    • AJNR Case Collection
    • Case of the Week Archive
    • Case of the Month Archive
    • Classic Case Archive
  • Special Collections
    • AJNR Awards
    • Low-Field MRI
    • Alzheimer Disease
    • ASNR Foundation Special Collection
    • Photon-Counting CT
    • View All
  • Multimedia
    • AJNR Podcasts
    • AJNR SCANtastic
    • Trainee Corner
    • MRI Safety Corner
    • Imaging Protocols
  • For Authors
    • Submit a Manuscript
    • Submit a Video Article
    • Submit an eLetter to the Editor/Response
    • Manuscript Submission Guidelines
    • Statistical Tips
    • Fast Publishing of Accepted Manuscripts
    • Graphical Abstract Preparation
    • Imaging Protocol Submission
    • Author Policies
  • About Us
    • About AJNR
    • Editorial Board
    • Editorial Board Alumni
  • More
    • Become a Reviewer/Academy of Reviewers
    • Subscribers
    • Permissions
    • Alerts
    • Feedback
    • Advertisers
    • ASNR Home

User menu

  • Alerts
  • Log in

Search

  • Advanced search
American Journal of Neuroradiology
American Journal of Neuroradiology

American Journal of Neuroradiology

ASHNR American Society of Functional Neuroradiology ASHNR American Society of Pediatric Neuroradiology ASSR
  • Alerts
  • Log in

Advanced Search

  • Home
  • Content
    • Current Issue
    • Accepted Manuscripts
    • Article Preview
    • Past Issue Archive
    • Video Articles
    • AJNR Case Collection
    • Case of the Week Archive
    • Case of the Month Archive
    • Classic Case Archive
  • Special Collections
    • AJNR Awards
    • Low-Field MRI
    • Alzheimer Disease
    • ASNR Foundation Special Collection
    • Photon-Counting CT
    • View All
  • Multimedia
    • AJNR Podcasts
    • AJNR SCANtastic
    • Trainee Corner
    • MRI Safety Corner
    • Imaging Protocols
  • For Authors
    • Submit a Manuscript
    • Submit a Video Article
    • Submit an eLetter to the Editor/Response
    • Manuscript Submission Guidelines
    • Statistical Tips
    • Fast Publishing of Accepted Manuscripts
    • Graphical Abstract Preparation
    • Imaging Protocol Submission
    • Author Policies
  • About Us
    • About AJNR
    • Editorial Board
    • Editorial Board Alumni
  • More
    • Become a Reviewer/Academy of Reviewers
    • Subscribers
    • Permissions
    • Alerts
    • Feedback
    • Advertisers
    • ASNR Home
  • Follow AJNR on Twitter
  • Visit AJNR on Facebook
  • Follow AJNR on Instagram
  • Join AJNR on LinkedIn
  • RSS Feeds

AJNR Awards, New Junior Editors, and more. Read the latest AJNR updates

Research ArticleBrainE

Differentiation between Oligodendroglioma Genotypes Using Dynamic Susceptibility Contrast Perfusion-Weighted Imaging and Proton MR Spectroscopy

S. Chawla, J. Krejza, A. Vossough, Y. Zhang, G.S. Kapoor, S. Wang, D.M. O'Rourke, E.R. Melhem and H. Poptani
American Journal of Neuroradiology August 2013, 34 (8) 1542-1549; DOI: https://doi.org/10.3174/ajnr.A3384
S. Chawla
aFrom the Departments of Radiology (S.C., J.K., A.V., Y.Z., S.W., E.R.M., H.P.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
J. Krejza
aFrom the Departments of Radiology (S.C., J.K., A.V., Y.Z., S.W., E.R.M., H.P.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
A. Vossough
aFrom the Departments of Radiology (S.C., J.K., A.V., Y.Z., S.W., E.R.M., H.P.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Y. Zhang
aFrom the Departments of Radiology (S.C., J.K., A.V., Y.Z., S.W., E.R.M., H.P.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
G.S. Kapoor
bNeurosurgery (G.S.K., D.M.O.), University of Pennsylvania, Philadelphia, Pennsylvania.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
S. Wang
aFrom the Departments of Radiology (S.C., J.K., A.V., Y.Z., S.W., E.R.M., H.P.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
D.M. O'Rourke
bNeurosurgery (G.S.K., D.M.O.), University of Pennsylvania, Philadelphia, Pennsylvania.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
E.R. Melhem
aFrom the Departments of Radiology (S.C., J.K., A.V., Y.Z., S.W., E.R.M., H.P.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
H. Poptani
aFrom the Departments of Radiology (S.C., J.K., A.V., Y.Z., S.W., E.R.M., H.P.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • Responses
  • References
  • PDF
Loading

REFERENCES

  1. 1.↵
    1. Engelhard HH,
    2. Stelea A,
    3. Cochran EJ
    . Oligodendroglioma: pathology and molecular biology. Surg Neurol 2002;58:111–17
    CrossRefPubMedWeb of Science
  2. 2.↵
    1. Kleihues P,
    2. Louis DN,
    3. Scheithauer BW,
    4. et al
    . The WHO classification of tumors of the nervous system. J Neuropathol Exp Neurol 2002;61:215–25
    PubMedWeb of Science
  3. 3.↵
    1. Bromberg JE,
    2. van den Bent MJ
    . Oligodendrogliomas: molecular biology and treatment. Oncologist 2009;14:155–63
    Abstract/FREE Full Text
  4. 4.↵
    1. Bigner SH,
    2. Rasheed BK,
    3. Wiltshire R,
    4. et al
    . Morphologic and molecular genetic aspects of oligodendroglial neoplasms. Neuro Oncol 1999;1:52–60
    Abstract/FREE Full Text
  5. 5.↵
    1. Aldape K,
    2. Burger PC,
    3. Perry A
    . Clinicopathologic aspects of 1p/19q loss and the diagnosis of oligodendroglioma. Arch Pathol Lab Med 2007;131:242–51
    PubMedWeb of Science
  6. 6.↵
    1. Hartmann C,
    2. von Deimling A
    . Molecular pathology of oligodendroglial tumors. Recent results. Cancer Res 2009;171:25–49
  7. 7.↵
    1. Cairncross JG,
    2. Ueki K,
    3. Zlatescu MC,
    4. et al
    . Specific genetic predictors of chemotherapeutic response and survival in patients with anaplastic oligodendrogliomas. J Natl Cancer Inst 1998;90:1473–79
    Abstract/FREE Full Text
  8. 8.↵
    1. Iwamoto FM,
    2. Nicolardi L,
    3. Demopoulos A,
    4. et al
    . Clinical relevance of 1p and 19q deletion for patients with WHO grade 2 and 3 gliomas. J Neurooncol 2008;88:293–98
    CrossRefPubMed
  9. 9.↵
    1. Walker C,
    2. Haylock B,
    3. Husband D,
    4. et al
    . Clinical use of genotype to predict chemosensitivity in oligodendroglial tumors. Neurology 2006;66:1661–67
    CrossRef
  10. 10.↵
    1. Jenkinson MD,
    2. Smith TS,
    3. Joyce K,
    4. et al
    . MRS of oligodendroglial tumors: correlation with histopathology and genetic subtypes. Neurology 2005;64:2085–89
    CrossRef
  11. 11.↵
    1. Whitmore RG,
    2. Krejza J,
    3. Kapoor GS,
    4. et al
    . Prediction of oligodendroglial tumor subtype and grade using perfusion weighted magnetic resonance imaging. J Neurosurg 2007;107:600–09
    CrossRefPubMedWeb of Science
  12. 12.↵
    1. Kapoor GS,
    2. Gocke TA,
    3. Chawla S,
    4. et al
    . Magnetic resonance perfusion-weighted imaging defines angiogenic subtypes of oligodendroglioma according to 1p19q and EGFR status. J Neurooncol 2009;92:373–86
    CrossRefPubMed
  13. 13.↵
    1. Spampinato MV,
    2. Smith JK,
    3. Kwock L,
    4. et al
    . Cerebral blood volume measurements and proton MR spectroscopy in grading of oligodendroglial tumors. AJR Am J Roentgenol 2007;188:204–12
    CrossRefPubMedWeb of Science
  14. 14.↵
    1. Daumas-Duport C,
    2. Tucker ML,
    3. Kolles H,
    4. et al
    . Oligodendrogliomas. Part II: A new grading system based on morphological and imaging criteria. J Neurooncol 1997;34:61–78
    CrossRefPubMed
  15. 15.↵
    1. Law M,
    2. Yang S,
    3. Wang H,
    4. et al
    . Glioma grading: sensitivity, specificity, and predictive values of perfusion MR imaging and proton MR spectroscopic imaging compared with conventional MR imaging. AJNR Am J Neuroradiol 2003;24:1989–98
    Abstract/FREE Full Text
  16. 16.↵
    1. Chawla S,
    2. Wang S,
    3. Wolf RL,
    4. et al
    . Arterial spin-labeling and MR spectroscopy in the differentiation of gliomas. AJNR Am J Neuroradiol 2007;28:1683–89
    Abstract/FREE Full Text
  17. 17.↵
    1. Hatanpaa KJ,
    2. Burger PC,
    3. Eshleman JR,
    4. et al
    . Molecular diagnosis of oligodendroglioma in paraffin sections. Lab Invest 2003;83:419–28
    PubMed
  18. 18.↵
    1. Morita N,
    2. Wang S,
    3. Chawla S,
    4. et al
    . Dynamic susceptibility contrast perfusion weighted imaging in grading of nonenhancing astrocytomas. J Magn Reson Imaging 2010;32:803–08
    CrossRefPubMed
  19. 19.↵
    1. Cha S,
    2. Knopp EA,
    3. Johnson G,
    4. et al
    . Intracranial mass lesions: dynamic contrast-enhanced susceptibility-weighted echo-planar perfusion MR imaging. Radiology 2002;223:11–29
    CrossRefPubMedWeb of Science
  20. 20.↵
    1. Provencher SW
    . Automatic quantitation of localized in vivo 1H spectra with LCModel. NMR Biomed 2001;14:260–64
    CrossRefPubMedWeb of Science
  21. 21.↵
    1. Lev MH,
    2. Ozsunar Y,
    3. Henson JW,
    4. et al
    . Glial tumor grading and outcome prediction using dynamic spin-echo MR susceptibility mapping compared with conventional contrast-enhanced MR: confounding effect of elevated rCBV of oligodendrogliomas. AJNR Am J Neuroradiol 2004;25:214–21
    Abstract/FREE Full Text
  22. 22.↵
    1. Megyesi JF,
    2. Kachur E,
    3. Lee DH,
    4. et al
    . Imaging correlates of molecular signatures in oligodendrogliomas. Clin Cancer Res 2004;10:4303–06
    Abstract/FREE Full Text
  23. 23.↵
    1. Jenkinson MD,
    2. du Plessis DG,
    3. Smith TS,
    4. et al
    . Histological growth patterns and genotype in oligodendroglial tumours: correlation with MRI features. Brain 2006;129:1884–91
    Abstract/FREE Full Text
  24. 24.↵
    1. Cairncross JG,
    2. Macdonald DR
    . Successful chemotherapy for recurrent malignant oligodendroglioma. Ann Neurol 1988;23:360–64
    CrossRefPubMedWeb of Science
  25. 25.↵
    1. van den Bent MJ,
    2. Taphoorn MJ,
    3. Brandes AA,
    4. et al
    . Phase II study of first-line chemotherapy with temozolomide in recurrent oligodendroglial tumors: the European Organization for Research and Treatment of Cancer Brain Tumor Group Study 26971. J Clin Oncol 2003;21:2525–28
    Abstract/FREE Full Text
  26. 26.↵
    1. Engelhard HH,
    2. Stelea A,
    3. Mundt A
    . Oligodendroglioma and anaplastic oligodendroglioma: clinical features, treatment, and prognosis. Surg Neurol 2003;60:443–56
    CrossRefPubMedWeb of Science
  27. 27.↵
    1. van den Bent MJ
    . Can chemotherapy replace radiotherapy in low-grade gliomas? Time for randomized studies. Semin Oncol 2003;30(6 Suppl 19):39–44
    PubMed
  28. 28.↵
    1. Iwadate Y,
    2. Matsutani T,
    3. Hasegawa Y,
    4. et al
    . Favorable long-term outcome of low-grade oligodendrogliomas irrespective of 1p/19q status when treated without radiotherapy. J Neurooncol 2011;102:443–49
    CrossRefPubMed
  29. 29.↵
    1. Wolf RL,
    2. Wang J,
    3. Wang S,
    4. et al
    . Grading of CNS neoplasms using continuous arterial spin labeled perfusion MR imaging at 3 Tesla. J Magn Reson Imaging 2005;22:475–82
    CrossRefPubMed
  30. 30.↵
    1. Di Costanzo A,
    2. Pollice S,
    3. Trojsi F,
    4. et al
    . Role of perfusion-weighted imaging at 3 Tesla in the assessment of malignancy of cerebral gliomas. Radiol Med 2008;113:134–43
    CrossRefPubMed
  31. 31.↵
    1. Xu M,
    2. See SJ,
    3. Ng WH,
    4. et al
    . Comparison of magnetic resonance spectroscopy and perfusion-weighted imaging in presurgical grading of oligodendroglial tumors. Neurosurgery 2005;56:919–26
    PubMedWeb of Science
  32. 32.↵
    1. Hsu YY,
    2. Chang CN,
    3. Wie KJ,
    4. et al
    . Proton magnetic resonance spectroscopic imaging of cerebral gliomas: correlation of metabolite ratios with histopathologic grading. Chang Gung Med J 2004;27:399–407
    PubMed
  33. 33.↵
    1. Chawla S,
    2. Oleaga L,
    3. Wang S,
    4. et al
    . Role of proton magnetic resonance spectroscopy in differentiating oligodendrogliomas from astrocytomas. J Neuroimaging 2010;20:3–8
    CrossRefPubMed
  34. 34.↵
    1. Chawla S,
    2. Zhang Y,
    3. Wang S,
    4. et al
    . Proton magnetic resonance spectroscopy in differentiating glioblastomas from primary cerebral lymphomas and brain metastases. J Comput Assist Tomogr 2010;34:836–41
    CrossRefPubMed
  35. 35.↵
    1. Thorsen F,
    2. Jirak D,
    3. Wang J,
    4. et al
    . Two distinct tumor phenotypes isolated from glioblastomas show different MRS characteristics. NMR Biomed 2008;21:830–38
    CrossRefPubMedWeb of Science
  36. 36.↵
    1. Nafe R,
    2. Glienke W,
    3. Hattingen E,
    4. et al
    . Correlation between amplification of the gene for the epidermal growth factor receptor (EGFR), data from preoperative proton-MR-spectroscopy (1HMRS) and histomorphometric data of glioblastomas. Anal Quant Cytol Histol 2007;29:199–207
    PubMed
  37. 37.↵
    1. Tate AR,
    2. Majos C,
    3. Moreno A,
    4. et al
    . Automated classification of short echo time in in vivo 1H brain tumor spectra: a multicenter study. Magn Reson Med 2003;49:29–36
    CrossRefPubMedWeb of Science
  38. 38.↵
    1. Di Costanzo A,
    2. Scarabino T,
    3. Trojsi F,
    4. et al
    . Multiparametric 3T MR approach to the assessment of cerebral gliomas: tumor extent and malignancy. Neuroradiology 2006;48:622–31
    CrossRefPubMed
  39. 39.↵
    1. Miller BL
    . A review of chemical issues in 1H NMR spectroscopy: N-acetyl-L-aspartate, creatine and choline. NMR Biomed 1991;4:47–52
    CrossRefPubMedWeb of Science
  40. 40.↵
    1. Henry RG,
    2. Vigneron DB,
    3. Fischbein NJ,
    4. et al
    . Comparison of relative cerebral blood volume and proton spectroscopy in patients with treated gliomas. AJNR Am J Neuroradiol 2000;21:357–66
    Abstract/FREE Full Text
  41. 41.↵
    1. Palfi S,
    2. Swanson KR,
    3. De Bouard S,
    4. et al
    . Correlation of in vitro infiltration with glioma histological type in organotypic brain slices. Br J Cancer 2004;91:745–52
    PubMedWeb of Science
  42. 42.↵
    1. de Groot J,
    2. Sontheimer H
    . Glutamate and the biology of gliomas. Glia 2011;59:1181–89
    CrossRefPubMedWeb of Science
  43. 43.↵
    1. Lee YY,
    2. Van Tassel P
    . Intracranial oligodendrogliomas: imaging findings in 35 untreated cases. AJR Am J Roentgenol 1989;152:361–69
    CrossRefPubMedWeb of Science
  44. 44.↵
    1. Schmainda KM,
    2. Rand SD,
    3. Joseph AM,
    4. et al
    . Characterization of a first-pass gradient-echo spin-echo method to predict brain tumor grade and angiogenesis. AJNR Am J Neuroradiol 2004;25:1524–32
    Abstract/FREE Full Text
  45. 45.↵
    1. Quarles CC,
    2. Ward BD,
    3. Schmainda KM
    . Improving the reliability of obtaining tumor hemodynamic parameters in the presence of contrast agent extravasation. Magn Reson Med 2005;53:1307–16
    CrossRefPubMedWeb of Science
  46. 46.↵
    1. Donahue KM,
    2. Krouwer HG,
    3. Rand SD,
    4. et al
    . Utility of simultaneously acquired gradient-echo and spin-echo cerebral blood volume and morphology maps in brain tumor patients. Magn Reson Med 2000;43:845–53
    CrossRefPubMedWeb of Science
PreviousNext
Back to top

In this issue

American Journal of Neuroradiology: 34 (8)
American Journal of Neuroradiology
Vol. 34, Issue 8
1 Aug 2013
  • Table of Contents
  • Index by author
Advertisement
Print
Download PDF
Email Article

Thank you for your interest in spreading the word on American Journal of Neuroradiology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Differentiation between Oligodendroglioma Genotypes Using Dynamic Susceptibility Contrast Perfusion-Weighted Imaging and Proton MR Spectroscopy
(Your Name) has sent you a message from American Journal of Neuroradiology
(Your Name) thought you would like to see the American Journal of Neuroradiology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Cite this article
S. Chawla, J. Krejza, A. Vossough, Y. Zhang, G.S. Kapoor, S. Wang, D.M. O'Rourke, E.R. Melhem, H. Poptani
Differentiation between Oligodendroglioma Genotypes Using Dynamic Susceptibility Contrast Perfusion-Weighted Imaging and Proton MR Spectroscopy
American Journal of Neuroradiology Aug 2013, 34 (8) 1542-1549; DOI: 10.3174/ajnr.A3384

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
0 Responses
Respond to this article
Share
Bookmark this article
Differentiation between Oligodendroglioma Genotypes Using Dynamic Susceptibility Contrast Perfusion-Weighted Imaging and Proton MR Spectroscopy
S. Chawla, J. Krejza, A. Vossough, Y. Zhang, G.S. Kapoor, S. Wang, D.M. O'Rourke, E.R. Melhem, H. Poptani
American Journal of Neuroradiology Aug 2013, 34 (8) 1542-1549; DOI: 10.3174/ajnr.A3384
del.icio.us logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Purchase

Jump to section

  • Article
    • Abstract
    • ABBREVIATIONS:
    • Materials and Methods
    • Results
    • Discussion
    • Conclusions
    • Footnotes
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • Responses
  • References
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • Neuroimaging-Based Classification Algorithm for Predicting 1p/19q-Codeletion Status in IDH-Mutant Lower Grade Gliomas
  • Genetically Defined Oligodendroglioma Is Characterized by Indistinct Tumor Borders at MRI
  • Crossref
  • Google Scholar

This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.

More in this TOC Section

  • White Matter Alterations in the Brains of Patients with Active, Remitted, and Cured Cushing Syndrome: A DTI Study
  • Qualitative and Quantitative Analysis of MR Imaging Findings in Patients with Middle Cerebral Artery Stroke Implanted with Mesenchymal Stem Cells
  • Fast Contrast-Enhanced 4D MRA and 4D Flow MRI Using Constrained Reconstruction (HYPRFlow): Potential Applications for Brain Arteriovenous Malformations
Show more Brain

Similar Articles

Advertisement

Indexed Content

  • Current Issue
  • Accepted Manuscripts
  • Article Preview
  • Past Issues
  • Editorials
  • Editor's Choice
  • Fellows' Journal Club
  • Letters to the Editor
  • Video Articles

Cases

  • Case Collection
  • Archive - Case of the Week
  • Archive - Case of the Month
  • Archive - Classic Case

More from AJNR

  • Trainee Corner
  • Imaging Protocols
  • MRI Safety Corner
  • Book Reviews

Multimedia

  • AJNR Podcasts
  • AJNR Scantastics

Resources

  • Turnaround Time
  • Submit a Manuscript
  • Submit a Video Article
  • Submit an eLetter to the Editor/Response
  • Manuscript Submission Guidelines
  • Statistical Tips
  • Fast Publishing of Accepted Manuscripts
  • Graphical Abstract Preparation
  • Imaging Protocol Submission
  • Evidence-Based Medicine Level Guide
  • Publishing Checklists
  • Author Policies
  • Become a Reviewer/Academy of Reviewers
  • News and Updates

About Us

  • About AJNR
  • Editorial Board
  • Editorial Board Alumni
  • Alerts
  • Permissions
  • Not an AJNR Subscriber? Join Now
  • Advertise with Us
  • Librarian Resources
  • Feedback
  • Terms and Conditions
  • AJNR Editorial Board Alumni

American Society of Neuroradiology

  • Not an ASNR Member? Join Now

© 2025 by the American Society of Neuroradiology All rights, including for text and data mining, AI training, and similar technologies, are reserved.
Print ISSN: 0195-6108 Online ISSN: 1936-959X

Powered by HighWire